Pharmacien Assurance Qualité
About the job
- A Doctor of Pharmacy degree and a defended thesis are required.
- First experience at an operating site is required; experience in the production of biological and/or sterile/aseptic medicines is preferred.
- Proficiency with quality tools and indicators and lean management methods, including 5S, GEMBA, Kaizen, and spaghetti diagrams, is required.
- The role requires field orientation, agility, listening and communication skills, and the ability to work in teams and across functions.
- Support operational staff and act as the Quality Assurance contact for assigned support services, including Production, Technical, and analytical laboratory teams.
- Ensure compliance with applicable pharmaceutical regulations.
- Coordinate development of quality assurance tools, including procedures, checklists, and trend analyses, and approve quality documentation within the assigned scope.
- Lead Quality Assurance review of operating data for assigned sectors and ensure deviations are handled appropriately.
- Manage change control, deviation, and CAPA quality processes within the assigned scope.
- Maintain a field presence, manage anomalies in real time, and conduct housekeeping visits, 5S activities, and GEMBA walks.
- Manage quality assurance sector performance and monitoring key performance indicators.
- Participate in preparation of Product Quality Reviews.
- Analyze and approve commissioning deliverables from the User Requirement Specifications stage, as well as qualification and validation deliverables.
- Participate in preparation for technical shutdowns and in operations and conditions for restart.
- Participate in internal and external audits and inspections.
- Provide tutoring and training.
- Experience at an operating site in the production of biological and/or sterile/aseptic medicines is preferred.
About the company
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Arras released first medicines in 2025, proving commercialization after heavy capital spending.
- LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
- France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.
What critics are saying
- EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
- LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
- A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.
What makes LFB unique
- French state-owned sole domestic plasma fractionator anchors national medicine supply.
- Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
- Europlasma and Amber Plasma give LFB 24 Central European collection centers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Unlimited Paid Time Off
- Flexible Work Hours
- Paid Vacation
- Hybrid Work Options
- Wellness Program
- Mental Health Support
- Phone/Internet Stipend
- Home Office Stipend
- Stock Options